Gottlieb Added to FasterCures Board

Former FDA Commissioner Scott Gottlieb has been appointed to the FasterCures advisory board. As a board member, Gottlieb will “leverage decades of experience to provide counsel to the FasterCures team in a variety of areas, including how to best engage patients in research, creating new pathways to innovation through novel financial incentives, and the ways in which a higher-functioning biomedical research system can be advanced,” executive director Tanisha Carino said in an email to FDA Webview.

FasterCures, which is part of the Milken Institute, is “working to build a biomedical research and development system that is effective, efficient, and driven by a clear vision: patient needs above all else,” the group says. “Our programs are focused on enabling patients to more easily participate in medical research, creating better pathways to medical innovation, and advancing a high-performing biomedical R&D system. Our network includes top disease foundations, the philanthropic community, financial institutions, and patient advocates.”